raloxifene hydrochloride has been researched along with Fibroid in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 20 (71.43) | 29.6817 |
| 2010's | 6 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, HU; Cohen, IR; Dally, RD; Dodge, JA; Fong, KC; Frank, SA; Geiser, AG; Hinklin, R; Hummel, CW; Jones, SA; Lewis, G; McCann, DJ; Rudmann, DG; Shepherd, TA; Tian, H; Wallace, OB; Wang, M; Wang, Y | 1 |
| Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS | 1 |
| Lethaby, A; Vollenhoven, B | 1 |
| Cecchini, RS; Costantino, JP; Cronin, WM; Ford, LG; Runowicz, CD; Vogel, VG; Wickerham, DL; Wolmark, N | 1 |
| Creasman, WT | 1 |
| McLaren, JS; Morris, E; Rymer, J | 1 |
| Chen, XY; Deng, L; Wu, T; Xie, L; Yang, J | 1 |
| Lombardi, G; Morelli, M; Nappi, C; Orio, F; Palomba, S; Panici, PL; Pellicano, M; Russo, T; Zullo, F; Zupi, E | 1 |
| Colao, A; Lombardi, G; Mastrantonio, P; Morelli, M; Nappi, C; Orio, F; Palomba, S; Pellicano, M; Russo, T; Zullo, F | 1 |
| Colao, A; Lombardi, G; Nappi, C; Orio, F; Palomba, S; Panici, PL; Russo, T; Tauchmanovà, L; Zullo, F; Zupi, E | 1 |
| Benatar, B; Darbhamulla, A; Watson, AJ | 1 |
| Crans, G; Eppel, W; Jirecek, S; Lee, A; Pavo, I; Wenzl, R | 1 |
| Colao, A; Lombardi, G; Mastrantonio, P; Nappi, C; Orio, F; Palomba, S; Russo, T; Sammartino, A; Sbano, FM; Zullo, F | 1 |
| Cascella, T; Doldo, P; Falbo, A; Lombardi, G; Mastrantonio, P; Nappi, C; Orio, F; Palomba, S; Russo, T; Zullo, F | 1 |
| Lombardi, G; Orio, F; Palomba, S; Zullo, F | 1 |
| Christopoulos, S; Rivera, JA; Small, D; Trifiro, M | 1 |
| Amati, A; Falbo, A; Orio, F; Palomba, S; Russo, T; Zullo, F | 1 |
| Cimini, V; Falbo, A; Lombardi, G; Orio, F; Palomba, S; Russo, T; Tolino, A; Zullo, F | 1 |
| Baytur, YB; Cilaker, S; Koyuncu, FM; Kurtul, O; Lacin, S; Oruc, S; Ozbilgin, K | 1 |
| Chen, W; Liu, J; Maruo, T; Matsuo, H; Wang, J; Xu, Q | 1 |
| Lingxia, X; Taixiang, W; Xiaoyan, C | 1 |
| Lethaby, AE; Vollenhoven, BJ | 1 |
| Chen, X; Wu, T; Xie, L | 1 |
| Bielawski, T; Miltyk, W; Palka, J; Surazynski, A; Wolczynski, S; Zbucka, M | 1 |
| Fuchs-Young, R; Hale, L; Howe, S; Miles, R; Walker, C | 1 |
| Fuchs-Young, R; Nicosia, SV; O'Brien, WF; Porter, GW; Porter, KB; Spellacy, WN; Tsibris, JC | 1 |
| Affinito, P; Di Carlo, C; Nappi, C; Palomba, S; Sammartino, A; Zullo, F | 1 |
| Ang, WC; Farrell, E; Vollenhoven, B | 1 |
9 review(s) available for raloxifene hydrochloride and Fibroid
| Article | Year |
|---|---|
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
Fibroids (uterine myomatosis, leiomyomas).
Topics: Humans; Leiomyoma; Menopause; Pain; Premenopause; Progestins; Raloxifene Hydrochloride; Regression Analysis; Uterine Neoplasms | 2011 |
Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update.
Topics: Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Endometriosis; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Leiomyoma; Lipids; Menstruation Disturbances; Norpregnenes; Parathyroid Hormone; Premenstrual Syndrome; Raloxifene Hydrochloride; Uterine Diseases; Vitamin D | 2012 |
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Topics: Adult; Female; Humans; Leiomyoma; Leuprolide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Neoplasms; Young Adult | 2012 |
Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Brachial Plexus Neuropathies; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasms; Nitriles; Radiography, Thoracic; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triazoles; Uterine Neoplasms | 2004 |
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Topics: Female; Humans; Leiomyoma; Leuprolide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Neoplasms | 2007 |
An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Topics: Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estrogen Antagonists; Evidence-Based Medicine; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Premenopause; Progestins; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Neoplasms | 2008 |
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Topics: Female; Humans; Leiomyoma; Leuprolide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Neoplasms | 2007 |
Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
Topics: Animals; Disease Models, Animal; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms | 2001 |
10 trial(s) available for raloxifene hydrochloride and Fibroid
| Article | Year |
|---|---|
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study.
Topics: Adult; Estrogen Antagonists; Female; Humans; Leiomyoma; Pilot Projects; Premenopause; Prospective Studies; Raloxifene Hydrochloride; Single-Blind Method; Treatment Outcome; Uterine Neoplasms | 2002 |
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism.
Topics: Adult; Body Mass Index; Bone and Bones; Bone Density; Calcium; Delayed-Action Preparations; Female; Femur; Humans; Leiomyoma; Leuprolide; Lumbar Vertebrae; Middle Aged; Osteoporosis; Phosphorus; Placebos; Premenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uterine Neoplasms | 2002 |
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial.
Topics: Delayed-Action Preparations; Female; Hot Flashes; Humans; Leiomyoma; Leuprolide; Menorrhagia; Pain; Patient Dropouts; Placebos; Premenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Uterine Neoplasms | 2002 |
Raloxifene prevents the growth of uterine leiomyomas in premenopausal women.
Topics: Adult; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Middle Aged; Premenopause; Prolactin; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Testosterone; Thyrotropin; Thyroxine; Ultrasonography; Uterine Neoplasms | 2004 |
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene.
Topics: Adult; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Leiomyoma; Leuprolide; Lipids; Middle Aged; Placebos; Premenopause; Raloxifene Hydrochloride; Triglycerides; Uterine Neoplasms; Vitamin B 12 | 2004 |
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Topics: Antineoplastic Agents, Hormonal; Blood Glucose; Bone Density; Bone Remodeling; Delayed-Action Preparations; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Lipids; Longitudinal Studies; Middle Aged; Patient Dropouts; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Severity of Illness Index; Treatment Outcome; Uterine Neoplasms; Vasomotor System | 2004 |
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life.
Topics: Adult; Affect; Analysis of Variance; Cognition; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Italy; Leiomyoma; Patient Selection; Placebos; Premenopause; Quality of Life; Raloxifene Hydrochloride; Single-Blind Method; Socioeconomic Factors; Uterine Neoplasms | 2004 |
Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women.
Topics: Apoptosis; Cell Proliferation; Double-Blind Method; Female; Growth Inhibitors; Humans; Leiomyoma; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Uterine Neoplasms | 2005 |
A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Topics: Adult; Antineoplastic Agents, Hormonal; Female; Genes, bcl-2; Goserelin; Humans; Leiomyoma; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tumor Suppressor Protein p53; Uterine Neoplasms | 2007 |
Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women.
Topics: Double-Blind Method; Estrogen Antagonists; Female; Humans; Leiomyoma; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Treatment Outcome; Ultrasonography; Uterine Neoplasms; Uterus | 2001 |
9 other study(ies) available for raloxifene hydrochloride and Fibroid
| Article | Year |
|---|---|
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
Topics: Animals; Binding Sites; Biological Availability; Cell Line; Cell Proliferation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Leiomyoma; Mammary Glands, Animal; Models, Molecular; Naphthalenes; Organ Size; Ovary; Piperidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Uterine Neoplasms; Uterus | 2005 |
Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Estrogen Antagonists; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Leiomyoma; Middle Aged; Ovarian Cysts; Polyps; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms; Vaginal Discharge | 2011 |
What is the significance of gynecologic symptoms in the participants in the NSABP study?
Topics: Breast Neoplasms; Female; Humans; Leiomyoma; Raloxifene Hydrochloride; Tamoxifen; Uterine Neoplasms | 2011 |
Recurrent vulval fibroids--an unusual indication for selective oestrogen receptor modulators (SERMs).
Topics: Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Hysterectomy; Immunohistochemistry; Leiomyoma; Middle Aged; Neoplasm Recurrence, Local; Raloxifene Hydrochloride; Treatment Outcome; Vulvar Neoplasms | 2004 |
Does raloxifene inhibit the growth of uterine fibroids?
Topics: Cell Division; Female; Humans; Leiomyoma; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uterine Neoplasms | 2004 |
Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro.
Topics: Adult; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Estradiol; Female; Humans; In Situ Nick-End Labeling; Leiomyoma; Middle Aged; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tumor Cells, Cultured; Uterine Neoplasms | 2007 |
Mechanism of collagen biosynthesis up-regulation in cultured leiomyoma cells.
Topics: Blotting, Western; Cells, Cultured; Collagen; Dipeptidases; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Estradiol; Female; Fulvestrant; Humans; Leiomyoma; Middle Aged; Myometrium; Raloxifene Hydrochloride; Tamoxifen; Up-Regulation | 2007 |
Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators.
Topics: Animals; Cell Division; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Leiomyoma; Phenotype; Piperidines; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1996 |
Effects of raloxifene in a guinea pig model for leiomyomas.
Topics: Animals; Estradiol; Estrogen Antagonists; Female; Guinea Pigs; Leiomyoma; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Ultrasonography; Uterine Neoplasms | 1998 |